Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Mithra Pharmaceuticals News

    0,22 € -0,45% -0,001 €
    17:19:03 Uhr Tradegate aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A14V4E
    ISIN: BE0974283153
    US-Symbol: MITPF
    Typ: Aktie

    Mithra Pharmaceuticals News

    08.03.24 - GlobeNewswire
    Mithra reports full year 2023 financial results
    Mithra reports full year 2023 financial results
    05.03.24 - GlobeNewswire
    Mithra announces changes to its executive management
    Mithra announces changes  to its executive management
    05.03.24 - GlobeNewswire
    Mithra initiates monetization process, receives bridge loan from existing lenders
    Mithra initiates monetization process, receives bridge loan from existing lenders Mithra appoints advisors and initiates a process to monetize its assets or execute a sale of its ...
    29.02.24 - GlobeNewswire
    DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
    DONESTA ® safety study for menopause completes treatment phase and advances to data management & reporting phase Mithra on-track for completion of Phase 3 study for ...
    15.02.24 - GlobeNewswire
    Mithra sells shares in Mayne Pharma
    Mithra sells shares in Mayne Pharma Mithra sold all 4,221,815 shares it held in Mayne Pharma for EUR ~12.8 million As the Mayne Pharma shares were pledged to the secured ...
    06.02.24 - GlobeNewswire
    Mithra updates on cash position
    Mithra updates on cash position Mithra's current cash of EUR 6.5 million is expected to cover its current cash runway through early March Mithra is actively engaging with ...
    21.12.23 - GlobeNewswire
    Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel
    20.12.23 - GlobeNewswire
    Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
    18.12.23 - GlobeNewswire
    Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial
    Mithra Receives Positive DSMB Opinion on DONESTA ® European Phase 3 Trial The DSMB recommends continuing the phase 3 trial in Europe following regular safety ...
    04.12.23 - GlobeNewswire
    Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
    30.11.23 - GlobeNewswire
    Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
    Mithra receives guidance from the FDA for the DONESTA ® NDA marketing authorization filing in the United States DONESTA ® for the treatment of vasomotor symptoms of ...
    28.11.23 - GlobeNewswire
    Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam
    Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam Five abstracts on the positive effect of E4 ...
    07.11.23 - GlobeNewswire
    Mithra’s NEXTSTELLIS® granted additional patent in the United States
    06.11.23 - GlobeNewswire
    Mithra releases invitation to its extraordinary securities holders’ meeting
    26.10.23 - GlobeNewswire
    Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada
    Mithra and Searchlight Pharma sign DONESTA ® licensing agreement for Canada Mithra to receive EUR 1.5 million milestone payout as a result of the signing of the agreement ...
    23.10.23 - GlobeNewswire
    Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement
    17.10.23 - GlobeNewswire
    Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting
    Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting
    11.10.23 - GlobeNewswire
    Shareholder Letter
    Dear Shareholders,  We write to you today with a deep sense of responsibility and transparency, driven by our commitment to the principles of sound corporate governance and the ...
    11.10.23 - GlobeNewswire
    Mithra announces update to the agenda of its upcoming special general shareholders’ meeting
    10.10.23 - GlobeNewswire
    Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress
    Mithra to hold joint symposium with partner Gedeon Richter on 11 October Four leading experts will outline why estrogens are critical in contraception and postmenopausal ...

    Newssuche

    Videos

    newspaper
    08:40 Uhr +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »